Mind-altering substances could be on the cusp of medical acceptability, with sovereign wealth funds Temasek and Mubadala in talks to fund biotech groups harnessing their potential
Psychedelics Firm Gets $100 Million Makeover Led By Yale Dropout bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Psychedelic biotech MAPS PBC rebrands to Lykos, snags $100M fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ MAPS Public Benefit Corporation ("MAPS PBC"), a company dedicated to transforming mental healthcare, announced an oversubscribed Series A.